MA29372B1 - Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique - Google Patents

Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique

Info

Publication number
MA29372B1
MA29372B1 MA30229A MA30229A MA29372B1 MA 29372 B1 MA29372 B1 MA 29372B1 MA 30229 A MA30229 A MA 30229A MA 30229 A MA30229 A MA 30229A MA 29372 B1 MA29372 B1 MA 29372B1
Authority
MA
Morocco
Prior art keywords
thioxylose
novel compounds
therapeutic use
compounds derived
thioxylopyranosis
Prior art date
Application number
MA30229A
Other languages
English (en)
Inventor
Veronique Barberousse
Michel Bondoux
Didier Thomas
Vincent Peyrou
Original Assignee
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa
Publication of MA29372B1 publication Critical patent/MA29372B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'INVENTION CONCERNE DE NOUVEAUX COMPOSÉS DU 5-THIOXYLOSE, PRÉFÉRENTIELLEMENT DES DÉRIVÉS DE TYPE 5-THIOXYLOPYRANOSE, AINSI QUE LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION EN TANT QUE PRINCIPE ACTIF DE MÉDICAMENTS, NOTAMMENT DESTINÉS AU TRAITEMENT OU À LA PRÉVENTION DES THROMBOSES OU DE L'INSUFFISANCE CARDIAQUE.
MA30229A 2005-03-25 2007-09-20 Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique MA29372B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502978A FR2883561B1 (fr) 2005-03-25 2005-03-25 Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique

Publications (1)

Publication Number Publication Date
MA29372B1 true MA29372B1 (fr) 2008-04-01

Family

ID=34955178

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30229A MA29372B1 (fr) 2005-03-25 2007-09-20 Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique

Country Status (18)

Country Link
US (1) US8148407B2 (fr)
EP (1) EP1861411A2 (fr)
JP (1) JP5036698B2 (fr)
KR (1) KR101336547B1 (fr)
CN (1) CN101146817B (fr)
AU (1) AU2006226251B2 (fr)
BR (1) BRPI0609211A2 (fr)
CA (1) CA2602698A1 (fr)
FR (1) FR2883561B1 (fr)
IL (1) IL185691A (fr)
MA (1) MA29372B1 (fr)
MX (1) MX2007011849A (fr)
NO (1) NO20074609L (fr)
RU (1) RU2412195C2 (fr)
TN (1) TNSN07362A1 (fr)
UA (1) UA92908C2 (fr)
WO (1) WO2006100413A2 (fr)
ZA (1) ZA200707947B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906248B1 (fr) * 2006-09-27 2008-12-26 Fournier S A Sa Lab Nouveaux derives de 5-thioxylopyranose
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614893B1 (fr) * 1987-05-04 1989-12-22 Fournier Innovation Synergie Nouveaux b-d-phenyl-thioxylosides, leur procede de preparation et leur application en therapeutique
US5246961A (en) * 1988-10-18 1993-09-21 Fournier Industrie Et Sante β-d-phenylthioxylosides, and their use as therapeutic agents
IE63544B1 (en) * 1988-10-18 1995-05-17 Fournier Ind & Sante Novel Beta-d-phenylthioxylosides their method of preparation and their use in therapy
JPH0753747B2 (ja) * 1988-11-03 1995-06-07 フルニエ アンデュストリ エ サンテ β―Ｄ―フェニルチオキシロシド、その調製方法および薬剤としての使用
ES2058580T3 (es) * 1988-11-03 1994-11-01 Fournier Ind & Sante Nuevos beta-d-feniltioxilosidos, su metodo de preparacion y su uso como medicamentos.
FR2660313B1 (fr) * 1990-04-02 1992-07-03 Fournier Ind & Sante Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.
FR2801055B1 (fr) * 1999-11-17 2002-02-08 Fournier Ind & Sante Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
WO2004089966A1 (fr) * 2003-04-01 2004-10-21 Taisho Pharmaceutical Co., Ltd. Procede de preparation selective de 5-thio-$g(b)-d-aldohexopyranoside heteroaryle
FR2860234B1 (fr) * 2003-09-25 2005-12-23 Fournier Lab Sa Nouveaux derives 666 du thioxylose

Also Published As

Publication number Publication date
MX2007011849A (es) 2007-10-03
TNSN07362A1 (fr) 2008-12-31
FR2883561B1 (fr) 2009-03-20
KR20070114357A (ko) 2007-12-03
KR101336547B1 (ko) 2013-12-03
WO2006100413A2 (fr) 2006-09-28
NO20074609L (no) 2007-12-12
CN101146817A (zh) 2008-03-19
CN101146817B (zh) 2011-08-17
FR2883561A1 (fr) 2006-09-29
US8148407B2 (en) 2012-04-03
CA2602698A1 (fr) 2006-09-28
AU2006226251A1 (en) 2006-09-28
BRPI0609211A2 (pt) 2010-03-02
ZA200707947B (en) 2008-12-31
IL185691A (en) 2012-02-29
US20080293768A1 (en) 2008-11-27
AU2006226251B2 (en) 2012-01-19
WO2006100413A9 (fr) 2007-10-18
JP2008535813A (ja) 2008-09-04
RU2007135251A (ru) 2009-04-27
IL185691A0 (en) 2008-01-06
EP1861411A2 (fr) 2007-12-05
WO2006100413A3 (fr) 2006-11-09
RU2412195C2 (ru) 2011-02-20
JP5036698B2 (ja) 2012-09-26
UA92908C2 (ru) 2010-12-27

Similar Documents

Publication Publication Date Title
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
NO20073719L (no) Kjemiske forbindelser
ATE489379T1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
NO20073615L (no) 3, 5-disubstituert og 3, 5, 7-trisubstituert-3H-oksazolo og 3H-tiazolo [4,5-d]pyrimidin-2-on forbindelser og prodrug derav
MA28008A1 (fr) Derives pyridyle et leur utilisation en tant qu'agents therapeutiques
MA28009A1 (fr) Derives de pyridazine et utilisation de ceux-ci en tant qu'agents therapeutiques
MA27427A1 (fr) Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
WO2001054681A8 (fr) Composition anti-stress
FR2939135B1 (fr) Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
MA29969B1 (fr) Formulations de quinolinones
NO20073760L (no) Triazolon-, tetrazolon- og imidazolonderivater for anvendelse som alfa-2C-adrenoreseptorantagonister
BR112023021131A2 (pt) Tratamento de tremor essencial
NO20076405L (no) Anvendelse av 24-nor-UDCA
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20052172L (no) 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter